|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts receivable | ||||||||||||||||||||
| Inventory, current portion | ||||||||||||||||||||
| Other receivable | ||||||||||||||||||||
| Convertible notes receivable, net of discount | ||||||||||||||||||||
| Receivable from sale of Stemsation stocks, net | ||||||||||||||||||||
| Investment in Stemsation stocks | ||||||||||||||||||||
| Settlement receivables | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Inventory, less current portion | ||||||||||||||||||||
| Due from employee - related party, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Security deposit | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accrued payroll due to officers | ||||||||||||||||||||
| Deferred revenue - related party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total deferred revenue - related party | ||||||||||||||||||||
| Due to a related party | ||||||||||||||||||||
| Accrued interest to a related party | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Other debt, net of discount, current portion | ||||||||||||||||||||
| Debt, net of discount, current portion | ||||||||||||||||||||
| Notes payable – Unrelated third parties, net | ||||||||||||||||||||
| Convertible notes payable, at fair value | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Unrelated Third Parties | ||||||||||||||||||||
| Other advances from an unrelated third party | ||||||||||||||||||||
| Unrelated Third Parties | ||||||||||||||||||||
| Total other advances from an unrelated third party | ||||||||||||||||||||
| SBA notes payable, current portion | ||||||||||||||||||||
| Operating lease obligations, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Notes payable, less current portion | ||||||||||||||||||||
| SBA notes payable, less current portion | ||||||||||||||||||||
| Unrelated Third Parties | ||||||||||||||||||||
| Total sBA notes payable, less current portion | ||||||||||||||||||||
| Operating lease obligations, less current portion | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ deficit: | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 20,000,000 shares authorized and 12,000,000 Series B Preferred shares authorized, issued and outstanding | ||||||||||||||||||||
| Total preferred stock, $0.001 par value, 20,000,000 shares authorized and 12,000,000 Series B Preferred shares authorized, issued and outstanding | ||||||||||||||||||||
| Common stock, $0.001 par value, 12,000,000,000 shares authorized; 7,159,727,214 and 7,099,727,214 shares issued and outstanding, respectively | ||||||||||||||||||||
| Common stock to be issued | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||||||||
Loading...
